secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001493152-26-000176
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions closes $10M private placement; funds FDA submission and expansion
--------------------------------------------------------------------------------

- Gross proceeds of ~$10M from sale of 2,298,850 units at $4.35/unit (common/pre-funded warrant + two Series K warrants).
- At closing, 105,000 shares and 2,193,850 pre-funded warrants issued; post-closing shares outstanding ~1.2M (excluding warrants).
- Series K warrants exercisable at $4.10/share for 5 years after registration statement declared effective by SEC.
- CEO: proceeds to fund FDA 510(k) submission for fingerprint drug screening system and international market expansion.
- Closing on Jan 2, 2026; resale registration statement to be filed by Jan 10, effective by Feb 14, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/0001493152-26-000176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer